Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn:
”Attending the International Society on Thrombosis and Haemostasis (ISTH) Congress is always one of the highlights of my year ISTH 2026, and I was especially excited to be in Paris, France this year.
I had the privilege of presenting our latest work on ADAMTS13/VWF dysregulation in sepsis on behalf of my graduate student, Olamilekan George.
Throughout my career, ISTH has played a transformative role by fostering an exceptional global network of colleagues, hosting a vibrant and scientifically outstanding congress, championing diversity and inclusivity, and providing awards and opportunities that enable early-career investigators to participate and grow.
The Society has created an environment where scientists at every stage can connect, collaborate, and thrive, and I am grateful to be part of this remarkable community.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering